Short Term rhG-CSF Priming; Before Chemotherapy Does Mobilize Blood Progenitors But Does Not Prevent Chemotherapy Induced Myelotoxicity: A Randomized Study of Patients with Non-Hodgkin's Lymphomas

References

• Soura L. M., Boone T. C., Gabrilove J., Lai P. H., Zsebo K. M., Murdock D. C., Chazin V. R., Bruczewcki J., Lu H., Chen K. K., Barendt J., Platzer E., Moore M. A. S., Mertelsmann R., Welte K. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic mycloid cells. Science 1986; 232: 61–65
   PubMed Web of Science ®Google Scholar
• Platzer E., Welte K., Grabilove J., Lu L., Harris P., Mertelsmann R., Moore M. A. S. Biological activities of a human pluripotent haemopoietic colony stimulating factor on normal and leukaemic cell. J. Exp. Med. 1985; 162: 1788–1801
   PubMed Web of Science ®Google Scholar
• Johnsen H. E., Hansen P. B., Plesner T., Jensen L., Gaarsdal E., Andersen H., Hansen S. W., Birgens H., Jacobsen G. K., Kjærsgaard E., Hansen N. E. Increased yield of myeloid progenitor cells in bone marrow harvested for autologous transplantation by pretreatment with recombinant human granulocyte-colony stimulating facto. Bone Marrow Transplant. 1992; 10: 229–234
   PubMed Web of Science ®Google Scholar
• Bronchud M. H., Potter M. R., Morgenstern G., Blasco M. J., Scharffe J. H., Thatcher N., Crowther D., Souza L. M., Alton N. K., Testa N. G., Dexter T. M. In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients. Br. J. Cancer 1988; 58: 64–69
   PubMed Web of Science ®Google Scholar
• Bronchud M. H., Scarffe J. H., Thatcher N., Crowther D., Souza L. M., Alton N. K., Testa N. G., Dexter T. M. Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br. J. Cancer 1987; 56: 809–813
   PubMed Web of Science ®Google Scholar
• Hansen P. B., Kjærsgaard E., Johnsen H. E., Gram J., Pedersen M., Nikolajsen K., Hansen N. E. Different membrane expression of CD11b and CD14 on blood neutrophils following in vivo administration of myeloid growth factors. Br. J. Hematol. 1993; 85: 50–56
   PubMed Web of Science ®Google Scholar
• Pettengell R., Gurney H., Radford J. A., Deakin D. P., James R., Wilkinson P. M., Kane K., Bentley J., Crowther D. Granulocyte colony-stimulating factor to prevent dose-limiting new tropenia in non-Hodgkin's lymphoma: a randomized controlled study. Blood 1992; 80: 1430–1436
   PubMed Web of Science ®Google Scholar
• Crawford J., Ozer H., Stoller R., Johnson D., Lyman G., Tabbara I., Kris M., Grous J., Picozzi V., Rausch G., Smith R., Gradishar W., Yahanda A., Vincent M., Stewart M., Glaspy J. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N. Engl. J. Med. 1991; 325: 164–170
   PubMed Web of Science ®Google Scholar
• Trillet-Lenoir V., Green J., Manegold C., Van Powel J., Gatzemeier U., Lebeau B., Depierre A., Johnson P., Decaster G., Tomita D., Ewen C. Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur. J. Cancer 1993; 29A: 319–324
   PubMed Web of Science ®Google Scholar
• Carbone P. P., Kaplan H., Musshoff K., Smithers D. W., Tubiani M. Report of the Committee on Hodgkin's disease staging classification. Cancer Rec. 1971; 31: 1860–1861
   PubMed Web of Science ®Google Scholar
• Stansfeld A. G., Diebold J., Noel H., Kapanci Y., Rilke F., Kelényi G., Sundstrom C., Lennert K., van Unnik J. A. M., Mioduszewska O., Wright D. H. Updated Kiel classification for lymphomas. Lancet 1988; 292–293
   PubMed Web of Science ®Google Scholar
• Ralfkiaer E. Immunohistological markers for the diagnosis of cutaneous lymphomas. Semin. Diag. Pathol. 1991; 8: 62–72
   PubMed Web of Science ®Google Scholar
• Wickramasinghe S. N. Normal haemopoiesis cellular composition of normal bone marrow. Blood and bone marrow, 3rd edn, S N Wickramasinghe. Churchill Livingstone, Edinburgh 1986; 41–72
   Google Scholar
• McKelvey E. M., Gottlieb J. A., Wilson H. E., Haut A., Talley R. W., Stephens R., Lane M., Gamble J. F., Janes S. E., Grozea P. N., Gutterman J., Coltman C., Moon T. E. Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma. Cancer 1976; 38: 1484–1493
   PubMed Web of Science ®Google Scholar
• Wright D. G., Meierovics A. I., Foxley J. M. Assessing the delivery of neutrophils to tissue in neutropenia. Blood 1986; 67: 1023–1030
   PubMed Web of Science ®Google Scholar
• Plesner T., Hansen N. E., Carlsen K. Estimation of PI-bound proteins on blood cells from PNH patients by quantitative flow cytometry. Br. J. Hematol. 1990; 75: 585–590
   PubMed Web of Science ®Google Scholar
• Coutinho L. H., Will A., Radford J., Schiro R., Testa N. G., Dexter M. T. Effects of recombinant human granulocyte colony-stimulating factor (CSF), human granulocyte macrophage-CSF, and gibbon interleukin-3 on hematopoiesis in longterm bone marrow culture. Blood 1990; 75: 2118–2129
   PubMed Web of Science ®Google Scholar
• Dührsen U., Villeval J-I., Boyd J., Kannourakis G., Morstyn G., Metcalf D. Effect of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood 1988; 72: 2074–2081
   PubMed Web of Science ®Google Scholar
• Gordon M. Y. Perspective: Physiological mechanisms in BMT and haemapoiesis-revisited. Bone Marrow Transplant. 1993; 11: 193–197
   PubMedGoogle Scholar
• Lord B. I. Myeloid cell kinetics in response to haemopoietic growth factors. In Bailliere's Clinical Hematology. Internationa. Practice and Res. 1992; 5(3)533–550
   Google Scholar
• Lord B. I., Bronchud M. H., Owens S., Chang J., Howell A., Souza L., Dexter T. M. The kinetics of human granu-lopoiesis following treatment with granulocyte colony-stimulating factor in vitro. Proc. Natl. Acad. Sci. USA 1989; 86: 9499–9503
   PubMed Web of Science ®Google Scholar
• Meropol N. J., Miller L. L., Korn E. L., Braitman L. E., MacDermott M. L., Schuster L. M. Severe myelosup-pression resulting from concurrent administration of granulocyte colony-stimulating factor and cytotoxic chemotherapy. J. Natl. Cancer Inst. 1992; 84: 1201–1203
   PubMed Web of Science ®Google Scholar